EMERGENCY USE

More in EMERGENCY USE

• Truenat receives EUA by DCGI for Nipah virus tests in India

  The testing platform can display results in less than an hour and has been used to detect nearly 30 diseases including TB, COVID-19, dengue, chikungunya, hepatitis, HPV in the past.

  

• WHO validates Sinovac Covid-19 vaccine

  WHO’s Emergency Use Listing (EUL) is a prerequisite for COVAX Facility vaccine supply and international procurement. It also allows countries to expedite their own regulatory approval to import and administer Covid-19 vaccines.

  

• Sri Lanka approves Pfizer Covid vaccine for emergency use

  Dr. Sudharshani Fernandopulle, the minister overseeing the fight against the epidemic, said in a statement the government would order 5 million doses of the Pfizer vaccine.

  

• Covid-19: WHO approves emergency use of China's Sinopharm Covid-19 vaccine

  The Sinopharm vaccine is produced by Beijing Bio-Institute of Biological Products Co Ltd, a subsidiary of China National Biotec Group (CNBG).

  

• Covaxin gets nod for use in Mexico

  The news of the approval was tweeted by Mexico’s foreign minister Marcelo Ebrard. Very timely decision by COFEPRIS to authorise the emergency use of the Covaxin vaccine manufactured in India. The options for vaccination against Covid-19 in Mexico are expanded, said the post by Ebrard

  

• WHO experts say Chinese jabs show 'safety', but data lacking

  The Chinese firms Sinovac and Sinopharm, whose Covid jabs are already being used in several countries, have submitted data in applications for the World Health Organization's emergency use listing (EUL) green light.

  

• Hong Kong approves Sinovac's vaccine for emergency use

  The Hong Kong Special Administrative Region (HKSAR) government on Thursday gave nod to the emergency use of the inactivated vaccine produced by Sinovac Biotech, two days after a panel of experts recommended the vaccine to the authorities.

  

• Pfizer withdraws application for emergency use of its Covid vaccine in India

  According to government sources, while Pfizer had sought clinical trial waiver for its vaccine, the SEC did not considered its proposal and insisted on a bridging study that it opined should be conducted on Indian population.

  

• AstraZeneca's Covid vaccine gets approval in Pakistan: Health Minister

  "DRAP granted emergency use authorisation to AstraZeneca's Covid vaccine," Pakistan's Health Minister Faisal Sultan told Reuters, referring to the Drug Regulatory Authority of Pakistan.

  

• Vaccine may not give you complete shield

  Doctors say despite Covid-19 shot, people will have to wear mask, follow social distancing

  

• Vaccine: DCGI panel to meet Bharat Biotech officials shortly

  A committee of experts assessing the coronavirus vaccines has called Hyderabad-based Bharat Biotech for a meeting at 1.30 pm on Saturday, a day after the firm was asked to present more data on its 'Covaxin' to get the go-ahead, a top source said.